DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 6,940.333 million compared to CNY 5,252.419 million a year ago. Operating income was CNY 817.885 million compared to CNY 509.102 million a year ago. Net income was CNY 594.731 million compared to CNY 380.714 million a year ago. Basic earnings per share from continuing operations was CNY 0.91 compared to CNY 0.6 a year ago.